Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE52.7700
- TODAY'S CHANGE (%)-1.2500 (-2.3140%)
- Bid / Lots49.6100/ 1
- Ask / Lots54.7500/ 1
- Open / Previous Close53.7500 / 54.0200
- Day Range
- 52 Week Range
- Volume719,142
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 23944 | 54.25 |
| 09:34 ET | 426 | 54.2 |
| 09:36 ET | 400 | 54.2 |
| 09:38 ET | 550 | 54.25 |
| 09:41 ET | 2824 | 54.235 |
| 09:43 ET | 2460 | 54.29 |
| 09:45 ET | 6100 | 54.25 |
| 09:48 ET | 614 | 54.25 |
| 09:50 ET | 2300 | 54.46 |
| 09:52 ET | 1200 | 54.64 |
| 09:54 ET | 2039 | 54.795 |
| 09:56 ET | 500 | 54.9 |
| 09:57 ET | 4605 | 54.97 |
| 09:59 ET | 2233 | 55 |
| 10:01 ET | 4036 | 54.955 |
| 10:03 ET | 983 | 54.955 |
| 10:06 ET | 726 | 54.955 |
| 10:08 ET | 980 | 54.9 |
| 10:10 ET | 11629 | 55.212 |
| 10:12 ET | 3930 | 55.28 |
| 10:14 ET | 700 | 55.16 |
| 10:15 ET | 3522 | 54.81 |
| 10:17 ET | 200 | 54.82 |
| 10:19 ET | 4313 | 54.945 |
| 10:21 ET | 712 | 54.93 |
| 10:24 ET | 1171 | 54.93 |
| 10:26 ET | 7815 | 54.85 |
| 10:28 ET | 7611 | 54.8 |
| 10:30 ET | 700 | 54.73 |
| 10:32 ET | 938 | 54.715 |
| 10:33 ET | 1976 | 54.88 |
| 10:35 ET | 300 | 55.06 |
| 10:37 ET | 1316 | 54.93 |
| 10:39 ET | 3143 | 54.69 |
| 10:42 ET | 3331 | 54.71 |
| 10:44 ET | 3801 | 54.6598 |
| 10:46 ET | 200 | 54.73 |
| 10:48 ET | 3162 | 54.72 |
| 10:50 ET | 2600 | 54.81 |
| 10:51 ET | 3269 | 54.82 |
| 10:53 ET | 1000 | 54.81 |
| 10:55 ET | 4296 | 54.63 |
| 10:57 ET | 1793 | 54.38 |
| 11:00 ET | 475 | 54.05 |
| 11:02 ET | 3820 | 53.8 |
| 11:04 ET | 2508 | 53.81 |
| 11:06 ET | 700 | 53.535 |
| 11:08 ET | 1612 | 53.49 |
| 11:09 ET | 400 | 53.435 |
| 11:11 ET | 1000 | 53.18 |
| 11:13 ET | 1700 | 53.05 |
| 11:15 ET | 1421 | 53.48 |
| 11:18 ET | 400 | 53.33 |
| 11:20 ET | 500 | 53.31 |
| 11:22 ET | 300 | 53.465 |
| 11:24 ET | 341 | 53.61 |
| 11:26 ET | 1437 | 53.56 |
| 11:27 ET | 300 | 53.46 |
| 11:29 ET | 432 | 53.31 |
| 11:31 ET | 988 | 53.3 |
| 11:33 ET | 400 | 53.231 |
| 11:36 ET | 320 | 53.1058 |
| 11:38 ET | 202 | 53.08 |
| 11:40 ET | 2401 | 53 |
| 11:42 ET | 1300 | 53.235 |
| 11:44 ET | 300 | 53.3 |
| 11:45 ET | 300 | 53.2 |
| 11:47 ET | 300 | 53.2 |
| 11:51 ET | 3234 | 53.49 |
| 11:54 ET | 536 | 53.59 |
| 11:56 ET | 3598 | 53.58 |
| 11:58 ET | 801 | 53.31 |
| 12:03 ET | 300 | 53.24 |
| 12:09 ET | 200 | 53.145 |
| 12:12 ET | 1987 | 53.305 |
| 12:14 ET | 3118 | 53.14 |
| 12:16 ET | 300 | 53.12 |
| 12:18 ET | 1247 | 53.2625 |
| 12:20 ET | 600 | 53.305 |
| 12:27 ET | 700 | 53.325 |
| 12:30 ET | 606 | 53.28 |
| 12:32 ET | 4326 | 53.27 |
| 12:34 ET | 1100 | 53.29 |
| 12:36 ET | 100 | 53.29 |
| 12:38 ET | 3117 | 53.38 |
| 12:39 ET | 500 | 53.41 |
| 12:41 ET | 200 | 53.385 |
| 12:43 ET | 500 | 53.33 |
| 12:45 ET | 900 | 53.305 |
| 12:48 ET | 2007 | 53.22 |
| 12:50 ET | 2300 | 53.18 |
| 12:52 ET | 2270 | 53.17 |
| 12:54 ET | 2918 | 53.12 |
| 12:56 ET | 1800 | 53.005 |
| 12:57 ET | 200 | 53.05 |
| 12:59 ET | 2316 | 52.98 |
| 01:01 ET | 600 | 52.775 |
| 01:03 ET | 1000 | 52.82 |
| 01:06 ET | 300 | 52.655 |
| 01:08 ET | 400 | 52.695 |
| 01:10 ET | 200 | 52.71 |
| 01:12 ET | 345 | 52.63 |
| 01:14 ET | 500 | 52.695 |
| 01:17 ET | 1530 | 52.72 |
| 01:19 ET | 1302 | 52.72 |
| 01:21 ET | 514 | 52.775 |
| 01:24 ET | 100 | 52.82 |
| 01:26 ET | 577 | 52.8 |
| 01:28 ET | 1046 | 52.835 |
| 01:30 ET | 1914 | 52.7325 |
| 01:32 ET | 1008 | 52.7 |
| 01:35 ET | 300 | 52.785 |
| 01:37 ET | 300 | 52.765 |
| 01:39 ET | 100 | 52.585 |
| 01:42 ET | 1023 | 52.59 |
| 01:44 ET | 800 | 52.61 |
| 01:46 ET | 400 | 52.68 |
| 01:48 ET | 200 | 52.755 |
| 01:50 ET | 913 | 52.725 |
| 01:51 ET | 100 | 52.715 |
| 01:53 ET | 100 | 52.76 |
| 01:57 ET | 300 | 52.745 |
| 02:00 ET | 300 | 52.81 |
| 02:02 ET | 1899 | 52.825 |
| 02:04 ET | 400 | 52.87 |
| 02:06 ET | 100 | 52.84 |
| 02:08 ET | 743 | 52.83 |
| 02:09 ET | 100 | 52.87 |
| 02:13 ET | 500 | 52.87 |
| 02:15 ET | 200 | 52.89 |
| 02:22 ET | 500 | 52.91 |
| 02:24 ET | 200 | 52.95 |
| 02:26 ET | 300 | 52.89 |
| 02:27 ET | 1300 | 52.7 |
| 02:29 ET | 600 | 52.71 |
| 02:31 ET | 300 | 52.645 |
| 02:33 ET | 1784 | 52.55 |
| 02:36 ET | 200 | 52.57 |
| 02:38 ET | 100 | 52.55 |
| 02:42 ET | 684 | 52.555 |
| 02:44 ET | 200 | 52.56 |
| 02:45 ET | 300 | 52.56 |
| 02:47 ET | 700 | 52.42 |
| 02:49 ET | 4196 | 52.585 |
| 02:51 ET | 425 | 52.4609 |
| 02:54 ET | 200 | 52.49 |
| 02:56 ET | 982 | 52.5799 |
| 02:58 ET | 200 | 52.515 |
| 03:00 ET | 601 | 52.375 |
| 03:02 ET | 600 | 52.33 |
| 03:03 ET | 1300 | 52.35 |
| 03:05 ET | 400 | 52.3 |
| 03:07 ET | 200 | 52.365 |
| 03:09 ET | 500 | 52.4 |
| 03:12 ET | 900 | 52.35 |
| 03:14 ET | 602 | 52.395 |
| 03:16 ET | 100 | 52.45 |
| 03:18 ET | 1460 | 52.41 |
| 03:20 ET | 853 | 52.425 |
| 03:21 ET | 600 | 52.36 |
| 03:23 ET | 300 | 52.38 |
| 03:25 ET | 3737 | 52.395 |
| 03:27 ET | 1000 | 52.4 |
| 03:30 ET | 1100 | 52.42 |
| 03:32 ET | 600 | 52.49 |
| 03:34 ET | 413 | 52.64 |
| 03:36 ET | 200 | 52.64 |
| 03:38 ET | 2720 | 52.62 |
| 03:39 ET | 1000 | 52.695 |
| 03:41 ET | 2047 | 52.65 |
| 03:43 ET | 2290 | 52.66 |
| 03:45 ET | 715 | 52.645 |
| 03:48 ET | 2918 | 52.64 |
| 03:50 ET | 2100 | 52.63 |
| 03:52 ET | 1538 | 52.63 |
| 03:54 ET | 1900 | 52.54 |
| 03:56 ET | 3400 | 52.49 |
| 03:57 ET | 6364 | 52.545 |
| 03:59 ET | 138429 | 52.77 |
Sep 27, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $80.00/Share by JMP Securities, from 10:56AM ET on Friday Sep 27, 2024 by Dow Jones
10:56AM ET on Friday Sep 27, 2024 by Dow Jones
Sep 26, 2024
Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly, from 4:05PM ET on Thursday Sep 26, 2024 by Dow Jones
4:05PM ET on Thursday Sep 26, 2024 by Dow Jones
Sep 16, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $90.00/Share by Cantor Fitzgerald, from 11:46AM ET on Monday Sep 16, 2024 by Dow Jones
11:46AM ET on Monday Sep 16, 2024 by Dow Jones
Sep 10, 2024
Crinetics Pharmaceuticals Announces September 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 4:40PM ET on Tuesday Sep 10, 2024 by Dow Jones
4:40PM ET on Tuesday Sep 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 4.3B | -14.0x | --- |
Immunovant Inc | 4.3B | -15.3x | --- |
Madrigal Pharmaceuticals Inc | 4.5B | -8.1x | --- |
Biohaven Ltd | 4.7B | -5.1x | --- |
BridgeBio Pharma Inc | 4.7B | -9.7x | --- |
Dyne Therapeutics Inc | 3.6B | -9.4x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.3B |
|---|---|
Revenue (TTM) | $1.4M |
Shares Outstanding | 80.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.62 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -14.0x |
Price/Sales (TTM) | 3,121.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -20,068.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
